NCT05870891

Brief Summary

The purpose of this study is to test the hypothesis that the equivalent glycemic load (EGL) value of portions of white bread containing 5 g available carbohydrate measured in this study is accurate and precise to within 1 gram. Additionally, the EGL of 7 low carbohydrate foods will be measured to determine their glycemic impact.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 23, 2023

Completed
23 days until next milestone

Study Start

First participant enrolled

June 15, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 3, 2023

Completed
24 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 27, 2023

Completed
Last Updated

April 22, 2025

Status Verified

April 1, 2025

Enrollment Period

4 months

First QC Date

May 4, 2023

Last Update Submit

April 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Equivalent glycemic load

    Equivalent glycemic load (EGL) for each test food, expressed as \[EGL = T/(W/Cwb)\] where T is the plasma glucose incremental area under the curve over 120 minutes (iAUC) elicited by one serving of test food, W is the mean iAUC elicited by the mean of two WB20 tests and Cwb is the amount of available carbohydrate in the WB20.

    -5 minutes to 120 minutes

Secondary Outcomes (2)

  • Insulin iAUC over 120 minutes

    -5 minutes to 120 minutes

  • Glucose iAUC over 120 minutes

    -5 minutes to 120 minutes

Study Arms (9)

Peanut Butter Cereal

EXPERIMENTAL

Consumption of Peanut Butter Cereal

Other: Food

Cinnamon Almond Cereal

EXPERIMENTAL

Consumption of Cinnamon Almond Cereal

Other: Food

Sriracha Crisps

EXPERIMENTAL

Consumption of Sriracha Crisps

Other: Food

Cheddar Crisps

EXPERIMENTAL

Consumption of Cheddar Crisps

Other: Food

Almond Blueberry Butter Bar

EXPERIMENTAL

Consumption of Almond Blueberry Butter Bar

Other: Food

Peanut Butter and Dark Chocolate Bar

EXPERIMENTAL

Consumption of Peanut Butter and Dark Chocolate Bar

Other: Food

Almond Dark Chocolate Bar

EXPERIMENTAL

Consumption of Almond Dark Chocolate Bar

Other: Food

White Bread 5 g available carbohydrate

EXPERIMENTAL

Consumption of white bread containing 5 g available carbohydrate

Other: Food

White Bread 20 g available carbohydrate

ACTIVE COMPARATOR

Consumption of white bread containing 20 g available carbohydrate

Other: Food

Interventions

FoodOTHER

Food

Almond Blueberry Butter BarAlmond Dark Chocolate BarCheddar CrispsCinnamon Almond CerealPeanut Butter CerealPeanut Butter and Dark Chocolate BarSriracha CrispsWhite Bread 20 g available carbohydrateWhite Bread 5 g available carbohydrate

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18-75 inclusive
  • Willing to abstain from unusual strenuous exercise and consuming alcoholic drinks for 24 hours before study days
  • Willing to refrain from smoking tobacco or marijuana for 12h before and during study visits
  • Understanding the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator
  • Subjects must be eligible to receive income in Canada and be covered by a health insurance plan such as OHIP

You may not qualify if:

  • Pregnant or lactating individuals
  • Personal history of diabetes
  • Major trauma or surgical event within 3 months of screening
  • The presence of any laboratory result, health condition, illness or drug use that increases risk to the subject or to others or may affect the results, as judged by the Qualified Investigator
  • Unwillingness or inability to comply with experimental procedures and to follow INQUIS safety guidelines
  • Known intolerance, sensitivity, or allergy to any ingredients in the study test meals. All allergens should be assumed to be a result of manufacturing practices.
  • Subject is currently participating or recently (within 30 days of screening) participated in a clinical trial involving long-term exposure (greater than 24 hours) to an investigational drug, nutritional supplement or lifestyle modification

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

INQUIS Clinical Research, Ltd.

Toronto, Ontario, M5C 2N8, Canada

Location

Related Publications (1)

  • Wolever TM, Miller K, Banh T. Equivalent Glycemic Load and Insulinemic Responses Elicited by Low-Carbohydrate Foods: A Randomized Trial in Healthy Adults. Curr Dev Nutr. 2025 Oct 30;9(12):107594. doi: 10.1016/j.cdnut.2025.107594. eCollection 2025 Dec.

MeSH Terms

Interventions

Food

Intervention Hierarchy (Ancestors)

Diet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2023

First Posted

May 23, 2023

Study Start

June 15, 2023

Primary Completion

October 3, 2023

Study Completion

October 27, 2023

Last Updated

April 22, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

De-identified participant data pertaining to glucose and insulin measurements will be shared upon reasonable request.

Time Frame
De-identified participant data pertaining to glucose and insulin measurements will be available after publication and will be available until 3 years after the publication date.
Access Criteria
Please contact the study sponsor to request access to the data.

Locations